LYEL

NasdaqGS

Lyell Immunopharma, Inc.

$12.52

+1.76% today

filing 2026-06-15 · 6d behind

Price

hover · 1 move explained

29 sells

Market cap

$297.28M

Float

10.4M

44% public

Short % float

Pro

Days to cover

Pro

AI BriefPro

Plain-English read on LYEL's signals — what's in favor and the red flags.

Unlock with Pro

Analyst · 6

Buy

$37.17+196.9%Street target

$12.00target range$49.00

Earnings

Beat 3 of last 4

+19.4%

2025-06

+19.4%

2025-09

-244%

2025-12

+53.5%

2026-03

Type	Date	Insider	Title	Shares	Price	Value
Other	2026-06-18	Innovative Cellular Therapeutics Holdings Ltd	—	66,500	—	—
Sell	2026-06-15	Seely Lynn	President and CEO	388	$18.91	$7.3K
Sell	2026-06-15	Lee Gary K.	Chief Scientific Officer	130	$18.92	$2.5K
Sell	2026-06-15	Hill Stephen J.	Chief Operating Officer	89	$18.92	$1.7K
Sell	2026-06-15	Bulis Veronica Sanchez	VP, Corporate Controller	217	$18.91	$4.1K

Other

Innovative Cellular Therapeutics Holdings Ltd

2026-06-18

—

66,500 shares

Sell

Seely Lynn

President and CEO · 2026-06-15

$7.3K

388 @ $18.91

Sell

Lee Gary K.

Chief Scientific Officer · 2026-06-15

$2.5K

130 @ $18.92

Sell

Hill Stephen J.

Chief Operating Officer · 2026-06-15

$1.7K

89 @ $18.92

Sell

Bulis Veronica Sanchez

VP, Corporate Controller · 2026-06-15

$4.1K

217 @ $18.91

34 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →